Interactions between magnesium and vitamin D: Possible implications in the immune system

Magnesium Research

Volumn 9, Issue 3, 1996, Pages 185-203

  McCoy, Harriett ^a   Kenney, Mary Alice ^a  

^a Arkansas Agricultural Experiment Station   (United States)

Author keywords

1,25 dihydroxyvitamin D3. 1,25(OH)2D3; Calcitriol; Immune system; Immunity; Magnesium; Vitamin D

Indexed keywords

CALCITRIOL RECEPTOR; CALCIUM; MAGNESIUM; VITAMIN D;

ANIMAL; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; CALCIUM; HUMANS; IMMUNE SYSTEM; MAGNESIUM; RECEPTORS, CALCITRIOL; VITAMIN D;

EID: 0030252740     PISSN: 09531424     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (197)

1. McCoy, H. & Kenney, M.A. (1992): Magnesium and immune function: recent findings. Magnes. Res. 5, 281-293.
2. McCoy, H. & Kenney, M.A. (1992): A review of biointeractions of Ni and Mg. II. Immune system and oncology. Magnes. Res. 5, 223-232.
3. McCoy, J.H. & Kenney, M.A. (1984): Magnesium and immunocompetence. In: Nutrition, disease resistance, and immune function, Ed. R.R. Watson, pp. 223-247. New York: Marcel Dekker.
4. McCoy, J.H. & Kenney, M.A. (1987): Magnesium and immune function: a review. In: Magnesium in cellular processes and medicine, eds. B.M. Altura., J. Durlach & M.S. Seelig, pp. 196-211. Basel: Karger.
5. Kubena, K.S. (1993): The role of magnesium in immunity. J. Nutr. Immunol. 2, 107-126.
6. Durlach, J. (1975): Rapports experimentaux et cliniques entre magnésium et hypersensibilité. Rev. Franç. Allergol. 15, 133-146.
7. Lavarenne, J. (1975): L'AMP cyclique en immunoallergologie. Rev. Fran.ç Allergol. 15, 163-169.
8. Hass, G.M., Laing, G.H., Galt, R.M. & McCreary, P.A. (1981): Recent advances: immunopathology of magnesium deficiency in rats. Induction of tumors; incidence, transmission and prevention of lymphoma-leukemia. Magnes. Bull 1A, 217-228.
9. Galland, L. (1988): Magnesium and Immune function: an overview. Magnesium 7, 290-299.
10. Hunziker, N. (1990): Magnesium and its role in allergy. In: Metal ions in biological systems, Vol. 26, eds. H. Siegel & A. Siegel, pp. 531-547. New York: Marcel Dekker.
11. Lemire, J.M. (1992): Immunomodulatory role of 1,25-dihydroxyvitamin D3. J. Cell. Biochem. 49, 26-31.
12. Hewison, M. (1992): Vitamin D and the immune system. J. Endocrinol. 132, 173-175.
13. Amento, E.P. (1987): Vitamin D and the immune system. Steroids 49, 55-72.
14. 3 and the immune system.. Proc. Soc. Exp. Biol. Med. 191, 238-245.
15. Rigby, W.F.C. (1988): The immunobiology of vitamin D. Immunol. Today 9, 54-58.
16. 1 functions. J. Nutr. 125, 1704S-1708S.
17. Walters, M.R. (1992): Newly identified actions of the vitamin D endocrine system. Endocr. Rev. 13, 719-764.
18. Zofková, I. & Kancheva, R.L. (1995): The relationship between magnesium and calciotropic hormones. Magnes. Res. 8, 77-84.
19. 3: an overview. J. Nutr. 125, 1687S-1689S.
20. 3 receptors: gene regulation and genetic circuitry. FASEB J. 2, 3043-3053.
21. DeLuca, H.F. (1992): New concepts of vitamin D functions. In: Beyond, deficiency: new views on the function and health of effects of vitamins, eds H.E. Sauberlich & L.J. Machlin. Ann. N.Y. Acad. Sci. 669, 59-69.
22. DeLuca, H.F. (1993): Vitamin D: 1993. Nutr. Today 28 (6), 6-11.
23. Henry, H.L. & Norman, A.W. (1984): Vitamin D: metabolism and biological actions. Annu. Rev. Nutr. 4, 493-520.
24. Reichel, H. & Norman, A.W. (1989): Systemic effects of vitamin D. Annu. Rev. Med. 40, 71-78.
25. Reichel, H., Koeffler, H.P. & Norman, A.W. (1989): The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med. 320, 980-991.
26. Chan, W., Thabet, M.A.E.H & Wellons, M.D. (1993): Mode of action of 1,25-dihydroxyvitamin D. Nutr. Res. 13, 359-368.
27. Bikle, D.D. (1992): Clinical counterpoint: Vitamin D: New actions, new analogs, new therapeutic potential. Endocr. Rev. 13, 765-784.
28. 3 and gamma interferon on the phenotype of human peripheral blood monocyte-derived macrophages. Infect. Immun. 55, 2017-2020.
29. 3 of the multiplication of virulent tubercle bacilli in cultured human macrophages. Infect. Immun. 55, 2945-2950.
30. 3 receptors: structure and function in transcription. Annu. Rev. Nutr. 11, 189-216.
31. 3: potential relation of a plasmalemmal receptor to the acute enhancement of intestinal calcium transport in chick. J. Nutr. 125, 1695S-1698S.
32. Caffrey, J.M. & Farach-Carson, M.C. (1989): Vitamin D3 metabolites modulate dihydropyridine-sensitive calcium currents in clonal rat osteosarcoma cells. J. Biol. Chem. 264, 20265-20274.
33. + exchange by stimulating membrane phosphoinositide turnover and increasing cytosolic calcium in CaCo-2 cells. Endocrinology 131, 1125-1133.
34. +2 influx-dependent nongenomic pathways. J. Nutr. 125, 1699S-1703S.
35. Shany, S., Levy, R. & Chaimovitz, C. (1995): Effect of 1,25-dihydroxyvitamin D on the immune activity of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients. Nephron 69, 367-370.
36. Brown, A.J., Ritter, C.R., Finch, J.L., Morrissey, J., Martin, K.J., Murayama, E., Nishii, Y. & Slatopolsky, E. (1989): The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion. J. Clin. Invest. 84, 728-732.
37. 3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice. Endocrinology 124, 2645-2647.
38. 3-regulated human keratinocyte proliferation and differentiation: basic studies and their clinical application. J. Nutr. 125, 1709S-1714S.
39. Romani, A. & Scarpa, A. (1992): Regulation of cell magnesium. Arch. Biochem. Biophys. 298, 1-12.
40. Millart, H., Durlach, V. & Durlach, J. (1995): Red blood cell magnesium concentrations: analytical problems and significance. Magnes. Res. 8, 65-76.
41. Shils, M.E. (1990): Chapter 25. Magnesium. In: Present knowledge in nutrition, 6th ed., eds. M.L. Brown, pp. 224-232. Washington, D.C.: International Life Sciences Institute-Nutrition Foundation.
42. Grubbs, R.D. & Maguire, M.E. (1987): Magnesium as a regulatory cation: criteria and evaluation. Magnesium 6, 113-127.
43. Walker, G.M. (1986): Magnesium and cell cycle control: an update. Magnesium 5, 9-23.
44. 3. Magnes. Res. 5, 5-14.
45. Risco, F., Traba, M.L. & De La Piedra, C. (1995): Possible alterations to the in vivo 1,25(OH)D3 synthesis and its tissue distribution in magnesium-deficient rats. Magnes. Res. 8, 27-36.
46. Leicht, E., Schmidt-Gayk, H., Langer, H.-J., Sneige, N. & Biro, G. (1992): Hypomagnesaemia-induced hypocalcaemia: concentrations of parathyroid hormone, prolactin and 1,25-dihydroxyvitamin D during magnesium replenishment. Magnes. Res. 5, 33-36.
47. Rude, R.K., Adams, J.S., Ryzen, E., Endres, D.B., Niimi, H., Horst, R.L., Haddad, J.G. & Singer, F.R. (1985): Low serum concentrations of 1,25-dinydroxyvitamin D in human magnesium deficiency. J. Clin. Endocrinol. Metab. 61, 933-940.
48. 3 receptors and actions in human prostate cancer cell lines. Endocrinology 132, 1952-1960.
49. DeLuca, H.F. & Schnoes, H.K. (1983): Vitamin D: recent advances. Annu. Rev. Biochem. 52, 411-439.
50. Weaver, V.M. & Welsh, J.E. (1990): 1,25-Dihydroxycholecalciferol and the genesis of hypocalcaemia in magnesium-deficient chicks. Magnes. Res. 3, 171-177.
51. 3 production in the isolated perfused rat kidney in response to changing perfusate phosphorus concentrations and insulin-like growth factor. J. Nutr. Biochem. 4, 158-161.
52. 3 receptor to magnesium depletion in the rat. Endocrinology 130, 2767-2777.
53. Carpenter, T.O., Cames, Jr., D.L. & Anast, C.S. (1987): Effect of magnesium depletion on metabolism of 25-hydroxyvitamin D in rats. Am. J. Physiol. 253, E106-E113.
54. Durlach, J. (1995): Editorial policy of Magnesium Research: general considerations on the quality criteria for biomedical papers and some complementary guidelines for the contributors to Magnesium Research. Magnes. Res. 8 (suppl. 1), 6-7.
55. Durlach, J., Bara, M. & Guiet-Bara, A. (1990): Magnesium and its relationship to oncology. In: Metal ions in biological systems, Vol. 26, eds. H. Siegel & A. Siegel, pp. 549-578. New York: Marcel Dekker.
56. Pointillart, A., Denis, I. & Colin, C. (1995): Effects of dietary vitamin D on magnesium absorption and bone mineral contents in pigs on normal magnesium intakes. Magnes. Res. 8, 19-26.
57. Hardwick, L.L. Jones, M.R., Brautbar, N. & Lee, D.B.N. (1991): Magnesium absorption: mechanisms and the influence of vitamin D, calcium and phosphate. J. Nutr. 121, 13-23.
58. Meintzer, R.B. & Steenbock, H. (1955): Vitamin D and magnesium absorption. J. Nutr. 56, 285-294.
59. Hanna, S. (1961): Influence of large doses of vitamin D on magnesium metabolism in rats. Metabolism 10, 735-743.
60. Lifshitz, F., Harrison, H.C. & Harrison, HE. (1967): Effects of vitamin D on magnesium metabolism in rats. Endocrinology 81, 849-853.
61. Levine, B.S., Brautbar, N., Walling, M.W., Lee, D.B.N. & Coburn, J.W. (1980): Effects of vitamin D and diet magnesium on magnesium metabolism. Am. J. Physiol. 239, E515-E523.
62. 2 level upon calcium, phosphorus and magnesium balance. J. Nutr. 85, 255-259.
63. Karbach, U. (1989): Cellular-mediated and diffusive magnesium transport across the descending colon of the rat. Gastroenterology 96, 1282-1289.
64. 3. Digestion 37, 35-42.
65. 3 regulates ATP-dependent calcium transport in baselateral plasma membranes of rat enterocytes. Biochim. Biophys. Acta 689, 170-172.
66. Martin, D.L., Melancon, M.J. & DeLuca, H.F. (1969): Vitamin D stimulated, calcium-dependent adenosine triphosphatase from brush borders of rat small intestine. Biochem. Biophys. Res. Commun. 35, 819-823.
67. Lane, S.M. & Lawson, D.E.M. (1978): Differentiation of the changes in alkaline phosphatase from calcium ion-activated adenosine triphosphatase activities associated with increased calcium absorption in chick intestine. Biochem. J. 174, 1067-1070.
68. Melancon, M.J. & DeLuca, H.F. (1970): Vitamin D stimulation of calcium-dependent adenosine triphosphatase in chick intestinal brush borders. Biochemistry 9, 1658-1664.
69. Zelinski, J.M., Sykes, D.E. & Weiser, M.M. (1991): The effect of vitamin D on rat intestinal plasma membrane Ca-pump mRNA. Biochem. Biophys. Res. Commun. 179, 749-755.
70. Lifshitz, F., Harrison, H. C. & Harrison, H.E. (1967): Response to vitamin D of magnesium deficient rats. Proc. Soc. Exp. Biol. Med. 125, 472-476.
71. 3 on swine coronary arteries. J. Am. Coll. Nutr. 9, 155-163.
72. 3 stimulates Ca-ATPase in a vascular smooth muscle cell line. Biochem. Biophys. Res. Commun. 150, 1138-1143.
73. McKenna, M.J., Hamilton, T.A. & Sussman, H.H. (1979): Comparison of human alkaline phosphatase isoenzymes. Biochem. J. 181, 67-73.
74. Scott, T. & Brewer, M. (1983): In: Concise encyclopedia of biochemistry, pp. 344-345. Berlin/New York: Walter de Gruyter.
75. Fatemi, S., Ryzen, E., Flores, J., Endres, D.B. & Rude, R.K. (1991): Effect of experimental human magnesium depletion on parathyroid hormone secretion and 1,25-dihydroxyvitamin D metabolism. J. Clin. Endocrinol. Metab. 73, 1067-1072.
76. Clements, M.R., Johnson, L. & Fraser, D.R. (1987): A new mechanism for induced vitamin D deficiency in calcium deprivation. Nature 324, 62-65.
77. Russell, J., Lettieri, D. & Sherwood, L.M. (1986): Suppression by 1,25(OH)Ds of transcription of the pre-proparathyroid hormone gene. Endocrinology 119, 2864-2866.
78. 2+ may result in impaired PTH secretion and PTH end-organ resistance. In: Magnesium in cellular processes and medicine, eds. B.M. Altura, J. Durlach & M.S. Seelig, pp. 183-195. Basel: Karger.
79. Delmez, J.A., Tindira, C., Grooms, P., Dusso, A., Windus, D.W. & Slatopolsky, E. (1982): Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium. J. Clin. Invest. 83, 1349-1355.
80. Silver, J., Russell, J. & Sherwood, L.M. (1985): Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc. Natl. Acad. Sci. USA 82, 4270-4273.
81. Littledike, E.T. & Goff, J. (1987): Hormonal control of magnesium metabolism - parathyroid hormone and vitamin D metabolites. In: Magnesium in cellular processes and medicine, eds. B.M. Altura, J. Durlach & M.S. Seelig, pp. 183-195. Basel: Karger.
82. Chaplin, H., Freedman, J., Massey, A. & Monroe, M.C. (1980): Characterization of red blood cells strongly coated in vitro by C3 via the alternative pathway. Transfusion 20, 256-262.
83. Stankiewicz, M., Migdalska, A., Bankowska, E. & Jeska, E.L. (1989): Complement activation, phagocytosis, tumor growth and parasitic infection after magnesium supplementation in diet of mice. Magnesium 8, 87-93.
84. Peterson, E.M., Zhong, G., Carlson, E. & de la Maza, L.M. (1988): Protective role of magnesium in the neutralization by antibodies of Chlamydia trachomatis infectivity. Infect. Immun. 56, 885-891.
85. Pryzdial, E.L.G. & Isenman, D.E. (1986): A reexamination of the role of magnesium in the human alternative pathway of complement. Molec. Immunol. 23, 87-96.
86. 3 and IFNγ on the synthesis of the second complement component. C2, by a human myeloid leukemia (HL-6O) cell line. J. Immunol. 140, 3082-3085.
87. 3. Proc. Natl. Acad. Sci. USA 78, 4990-4994.
88. 3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism. Proc. Natl. Acad. Sci. USA 80, 5583-5587.
89. 3 and their relation in alveolar macrophages. Proc. Natl. Acad. Sci. USA 81, 7112-7116.
90. 3 induces maturation of the human monocyte cell line U937, and, in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor. J. Clin. Invest 73, 731-739.
91. 3 induced differentiation of human myeloid leukemia cells. Biochem. Biophys. Res. Commun. 102, 937-943.
92. Mezzetti, G., Bagnara, G., Monti, M.G., Bonsi, L., Brunelli, M.A. & Barbiroli, B. (1984): 1α,25-dihydroxycholecalciferol and human histiocytic lymphoma cell line (U-937): the presence of receptor and inhibition of proliferation. Life Sci. 34, 2185-2191.
93. Dodd, R.C., Cohen, M.S., Newman, S.L. & Gray, T.K. (1983): Vitamin D metabolites change the phenotype of monoblastic U937 cells. Proc. Natl. Acad. Sci. USA 8, 7538-7541.
94. Srimaruta, N., Lee, P.D. & Lebenthal, E. (1987): Ontogenic changes in serum immunoglobulins and C3 in vitamin-D deficient and malnourished rats. Biol. Neonate 52, 317-326.
95. Benjamini, E. & Leskowitz, S. (1991): Chapter 5. Biological properties of immunoglobulins. In: Immunology: a short course, 2nd Ed, pp. 69-82. New York: Wiley-Liss.
96. Gallin, J.I. & Rosenthal, A.S. (1974): The regulatory role of divalent cations an human granulocyte chemotaxis. J. Cell Biol. 62, 594-609.
97. 3. J. Clin. Endocrinol. Metab. 69, 127-133.
98. 2+ in thymocytes from normal and Mg-deficient rats. Magnes. Bull. 9, 33-35.
99. Mills, G.B., Cheung, R.K., Grinstein, S. & Gelford, E.W. (1985): Interleukin 2-induced lymphocyte proliferation is independent of increases in cytosolic free calcium concentration. J. Immunol. 134, 2431-2435.
100. Sacco, N.A. & Filkins, J.P. (1988): Phagocytes and monokines: perspectives on metabolic regulation in sepsis. Magnesium 7, 281-289.
101. 3 in the myeloid cell differentiation. Proc. Soc. Exp. Biol. Med. 191, 214-220.
102. Taimi, M., Defacque, H., Commes, T., Favero, J., Caron, E., Marti, J. & Dornand, J. (1993): Effect of retinoic acid and vitamin D on the expression of interleukin-1β, tumour necrosis factor-α and interLeukin-6 in the human monocytic cell line U937. Immunology 79, 229-235.
103. 3 and retinoic acid in inducing U937 cell differentiation. J. Nutr. Sci. Vitaminol. 38, 415-426.
104. 3-induced terminal monocytic differentiation of human leukemic cell lines. J. Immunol. 150, 2418-2430.
105. 3. Cancer Res. 47, 2236-2242.
106. Yiangou, M. & Hadjipetrou-Kourounakis, L. (1989): Effect of magnesium deficiency on interleukin production by Fisher rats: effect of interleukins on reduced in vitro lymphocyte responses to concanavalin A and lipopolysaccharide. Int. Arch. Allergy Appl. Immunol. 89, 217-221.
107. 3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J. Clin. Invest 74, 657-661.
108. 3 of dimethyl sulfoxide-induced differentiation of Friend erythroleukemia cells. Biochem. Biophys. Res. Commun. 119, 807-813.
109. Tanaka, H., Abe, E., Miyaura, C., Kuribayashi, T., Konno, K., Nishii, Y. & Suda, T. (1982): 1α,25-Dihydroxychotecalciferol and a human myeloid leukaemia cell line (HL-60). The presence of a cytosol receptor and induction of differentiation. Biochem. J. 204, 713-719.
110. Flynn, A. (1984): Control of in vitro lymphocyte proliferation by copper, magnesium and zinc deficiency. J. Nutr. 114, 2034-2042.
111. Durlach, J. (1988): Chapter III. Secondary magnesium deficits, pp 113-194; Chapter V. Magnesium and therapeutics In: Magnesium in clinical practice, pp. 217-246. London: John Libbey.
112. Durlach, J. (1988): Chapter III. Secondary magnesium deficits, pp 113-194; Chapter V. Magnesium and therapeutics In: Magnesium in clinical practice, pp. 217-246. London: John Libbey.
113. 3 and the regulation of macrophage function. Calcif. Tissue Int. 33, 673-676.
114. Passwell, J.H., Schneeberger, E. & Merler, E. (1978): Cellular requirements for the formation of EA rosettes by human monocytes. Immunology 35, 863-872.
115. Walia, A.S., Shaw, D.R., Fuson, E.W., Andersson, B. & Lamon, E.W. (1980): Different divalent cation requirements for binding IgM complexes to lymphocytes and macrophages. J. Exp. Med. 151, 1528-1533.
116. Guerry, D., Dusak, B.A., Schreiber, A.D. & Cooper, R.A. (1978): B lymphocyte expression of a recognition locus for human monocytes and macrophages. J. Immunol. 121, 2446-2452.
117. 3 maintains adherence of human monocytes and protects them from thermal injury. J. Clin. Invest. 77, 1332-1339.
118. Flynn, A. (1985): In vitro levels of copper, magnesium and zinc required for mitogen stimulated T lymphocyte proliferation. Nutr. Res. 5, 487-495.
119. Weglicki, W.B., Stafford, R.E., Freedman, A.M., Cassidy, M.M. & Phillips, T.M. (1993): Modulation of cytokines and myocardial lesions by vitamin E and chloroquine in a Mg-deficient rat model. Am. J. Physiol. 264, C723-C726.
120. 3 on human lymphocytes and monocyte/ macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell. Immunol. 98, 311-322.
121. Wientroub, S., Winter, C.C., Wahl, S.M. & Wahl, L.M. (1989): Effect of vitamin D deficiency on macrophage and lymphocyte function in the rat. Calcif. Tissue Int. 44, 125-130.
122. Hiserodt, J.C., Britvan, L.J. & Targan, S.R. (1982): Characterization of the cytolytic reaction mechanism of the human natural killer (NK) lymphocyte: resolution into binding, programming, and killer cell-independent steps. J. Immunol. 129, 1782-1787.
123. MacLennan, I.C.M. & Goldstein, P. (1978): Recognition by cytolytic T and K cells: Identification in both systems of a divalent cation-dependent, cytochalasin A-sensitive step. J. Immunol. 121, 2541-2546.
124. Henney, C.S. & Bubbers, J.E. (1973): Studies on the mechanisms of lymphocyte-mediated cytolysis. I. The role of divalent cations in cytolysis by T lymphocytes. J. Immunol. 110, 63-72.
125. Gateley, M.K. & Mertz, E. (1979): Early steps in specific tumor cell lysis by sensitized mouse T lymphocytes. III. Resolution of two distinct roles for calcium in the cytolytic process. J. Immunol. 122, 482-489.
126. 2+ in the cytotoxic T lymphocyte reaction and in the secretion of Nα- benzyloxycarbonyl-L-lysine thiobenzyl ester-serine esterase by human T cell clones. J. Immunol. 7, 2173-2180.
127. 2+. Immunology 39, 109-117.
128. Flynn, A. & Yen, B.R. (1981): Mineral deficiency effects on the generation of cytotoxic T cells and T helper cell factors in vitro. J. Nutr. 111, 907-913.
129. Graziano, R.F., Erbe, D.V. & Fanger, M.W. (1989): The mechanisms of antibody-dependent killing mediated by lymphoid and myeloid cells are distinct based on different divalent cation requirements. J. Immunol. 143, 3894-3900.
130. 3 enhances the generation of nonspecific suppressor cells while inhibiting the induction of cytotoxic cells in a human MLR. Cell. Immunol. 140, 400-409.
131. 3. Cell. Immunol. 118, 328-336.
132. Benjamini, E. & Leskowitz, S. (1991): Chapter 11 The role of the major histocompatibility complex in the immune response. In: Immunology: a short course 2nd Ed, pp. 193-210. New York: Wiley-Liss.
133. Quesada, J.M., Serrano, I., Borrego, F., Martin, A., Peña, J. & Solana, R. (1995): Calcitriol effect on natural killer cells from hemodialyzed and normal subjects. Calcif. Tissue Int. 56, 113-117.
134. Benjamini, E. and Leskowitz, S. (1991):Chapter 9. The ontogeny (development) of cells involved in the immune response. In: Immunology: a short course, 2nd Ed, pp. 151-172. New York: Wiley-Liss.
135. Günther, T. & Averdunk, R. (1979): Reduced lectin stimulation of lymphocytes from magnesium-deficient rats. J. Clin. Chem. Clin. Biochem. 17, 51-55.
136. Armier, J., Guenounou, M., Lebel, B. & Gaudin-Harding, F. (1979): Histaminémia et réponse des cellules spléniques a la phytohémagglutinine au cours de la carence modérée en magnésium chez le rat. C.R. Acad. Sci. Paris 288, 971-974.
137. Morgan, J.I. and Perris, A.D. (1974): The influence of sex steroids on calcium- and magnesium-induced mitogenesis in isolated rat thymic lymphocytes. J. Cell. Physiol. 83, 287-296.
138. 3: a novel immunoregulatory hormone. Science 224, 1438-1439.
139. 3 (calcitriol). J. Clin. Invest. 74, 1451-1455.
140. 3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production. J. Immunol. 136, 2734-2740.
141. 3 receptor distribution and effects in subpopulations of normal human T lymphocytes. J. Clin. Endocrinol. Metab. 68, 774-779.
142. 3 inhibits selectively the mitogenic stimulation of mouse medullary thymocytes. Biochem. Biophys. Res. Commun. 123, 163-169.
143. 3 and glucocorticoids in the rat thymus gland. Endocrinology 124, 1532-1538.
144. 3 on human T lymphocyte activation and proliferation: a cell cycle analysis. J. Immunol. 135, 2279-2286.
145. Manolagas, S.C., Provvedini, D.M., Murray, E.J., Tsoukas, C.D. & Deftos, L.J. (1986): The antiproliferative effect of calcitriol on human peripheral blood mononuclear cells. J. Clin. Endocrinol. Metab. 63, 394-400.
146. Duffus, J.H. & Walker, G.M. (1987): Magnesium in mitosis and the cell cycle. In: Magnesium in cellular processes and medicine, eds. Altura, B.M., Durlach, J., Seelig, M.S., pp. 131-141. Basel: Karger.
147. McCoy, J.H. & Kenney, M.A. (1975): Depressed immune response in the magnesium-deficient rat. J. Nutr. 105, 791-797.
148. Alcock, N.W. & Shils, M.E. (1974 ): Serum immunoglobulin G in the magnesium-depleted rat. Proc. Soc. Exp. Biol. Med. 145, 855-858.
149. Elin, R.J. (1975): The effect of magnesium deficiency in mice on serum immunoglobulin concentrations and antibody plaque-forming cells. Proc. Soc. Exp. Biol. Med. 148, 620-624.
150. Prouvost-Danon, A., Larvor, P., Rayssiguier, Y., Wyczolkowska, J. & Durlach, J. (1975): Taux sérique d'anticorps réaginiques (IgE) chez la souris en carence magnésique. Rev. Franç. Allergol. 15, 147-150.
151. Windhauser, M.M., Kappel, L.C. & Hegsted, M. (1991): The humoral immune response in marginally and severely magnesium deficient rats. J. Nutr. Biochem. 2, 541-546.
152. 3 suppresses human T helper/inducer lymphocyte activity in vitro. J. Immunol. 134, 3032-3035.
153. 3-mediated inhibition of human B cell differentiation. Clin. Exp. Immunol. 69, 639-646.
154. 3 on in vitro immunoglobulin production in human B cells. J. Immunol. 136, 4427-4431.
155. Guenounou, M., Armier, J. & Gaudin-Harding, F. (1978): Effect of magnesium deficiency and food restriction on the immune response in young mice. Int. J. Vitam. Nutr. Res. 48, 290-295.
156. Weglicki, W.B., Phillips, T.M., Freedman, A.M., Cassidy, M.M. & Dickens, B.F. (1992): Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol. Cell. Biochem. 110, 169-173.
157. Haq, A.U. (1986): 1,25-dihydroxyvitamin D3 (calcitriol) suppresses IL-2 induced murine thymocyte proliferation. Thymus 8, 295-306.
158. 2, interieukin 1, and tumor necrosis factor α by human monocytes. Bone 13, 185-189.
159. 3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. Immunology 62, 229-234.
160. 2+/calmodulin-dependent kinase. Respiration 62, 89-94.
161. 3 activates secretion of hydrogen peroxide by human monocytes. J. Immunol. 136, 1049-1053.
162. Freedman, A.M., Atrakchi, A.H., Cassidy, M.M. & Weglicki, W.B. (1990): Magnesium deficiency-induced cardiomyopathy: protection by vitamin E. Biochem. Biophys. Res. Commun. 170, 1102-1106.
163. 1 clones. J. Immunol. 138, 3688-3694.
164. 2, and mononuclear cell factor production by U937 cells. Cell. Immunol. 97, 286-296.
165. Durlach, J. (1989): The Fifth International Magnesium Symposium of Kyoto. Magnes. Res. 2, 1-8.
166. Rayssiguier, Y., Gueux, E., Bussiére, L. & Durlach, J. (1993): Dietary magnesium affects susceptibility of lipoproteins and tissues to peroxidation. J. Am. Coll. Nutr. 12, 133-137.
167. Rayssiguier, Y., Mazur, A., Gueux, E. & Rock, E. (1994): Magnesium deficiency affects lipid metabolism and atherosclerosis processes by a mechanism involving inflammation and oxidative stress. Magnes. Res. 7 (suppl. 1), 46-47.
168. Weglicki, W.B. (1994): Antioxidant drugs and free radicals in magnesium deficiency. Magnes. Res. 7 (suppl. 1), 45-46.
169. Kenney, M.A. & McCoy, H. (1992): A review of biointeractions of Ni and Mg. I. Enzyme, endocrine, transport, and skeletal systems. Magnes. Res. 5, 215-222.
170. Cruse, J.M. & Lewis, R.E. (1994): Illustrated dictionary of immunology, Boca Raton, FL: CRC Press.
171. 3. Blood 76, 189-197.
172. Henrotte, J.G. (1979): Magnésium érythrocytaire et groupes HLA. C.R. Acad. Sci. Paris 289, 445-447.
173. Henrotte, J.G., Hannoun, C., Benech, A. & Dausset J. (1985): Relationship between postvaccinal anti-influenza antibodies, blood magnesium
174. Henrotte, J.G. (1988): Genetic regulation of blood and tissue magnesium content in mammals. Magnesium 7, 306-314.
175. Henrotte, J.G., Pla, M. and Dausset, J. (1990): HLA and H-2 associated variations of intra- and extracellular magnesium content. Proc. Natl. Acad. Sci. USA 87, 1894-1898.
176. Henrotte, J.G., Mouton, D., Colombani, J. & Frank-Riquer, G. (1982): Relation entre la concentration du magnésium érythrocytaire et l'intensité de la réponse immunitaire chez la Souris. C.R. Acad. Sci. Paris 295, 15-18.
177. Amyard, N., Leyris, A., Monier, C., Francés, H., Boulu, R.G. & Henrotte, J.G. (1994): Brain catecholamines, serotonin and their metabolites in mice selected for low (MGL) and high (MGH) blood magnesium levels. Magnes. Res. 8, 5-9.
178. Osborne-Pellegrin, M.J. & Henrotte, J.G. (1994): The variability of blood pressure in mice selected for low (MGL) and high (MGH) blood magnesium levels. Magnes. Res. 8, 11-17.
179. Durlach, J., Durlach, V., Rayssiguier, Y., Bara, M. & Guiet-Bara, A. (1992): Magnesium and blood pressure. II. Clinical studies. Magnes. Res. 5, 147-153.
180. Kasprzak, K.S. (1991): The role of oxidative damage in metal carcinogenicity. Chem. Res. Toxicol. 4, 604-615.
181. Nackerdien, Z., Kasprzak, K.S., Rao, G., Halliwell, B. & Dizdaroglu, M. (1991): Nickel (II)- and cobalt (II)-dependent damage by hydrogen peroxide to the DNA bases in isolated human chromatin. Cancer Res. 51, 5837-5842.
182. Lin, X.H., Sugiyama, M. & Costa, M. (1991): Differences in the effect of vitamin E on nickel sulfide or nickel chloride-induced chromosomal aberrations in mammalian cells. Mutat. Res. 260, 159-164.
183. 3. J. Nutr. 125, 1690S-1694S.
184. Cameron, I.L. and Smith, N.K.R. (1989): Cellular concentration of magnesium and other ions in relation to protein synthesis, cell proliferation, and cancer. Magnesium 8, 31-44.
185. Maurois, P., Delcourt, P., Slomianny, C., Gueux, E. & Rayssiguier, Y: (1995): Effect of dietary magnesium on the susceptibility of mice to infection by protozoan parasites of the Apicomplexa and Mastigophora phyla. Magnes. Res. 8, 159-166.
186. Rolla, G., Bucca, C., Arossa, W. & Bugiana, M (1987): Magnesium attenuates methacholine induced bronchoconstriction in asthmatics. Magnesium 6, 201-204.
187. Rolla, G., Bucca, C., Bugiana, M., Arossa, W. & Spinaci S (1987): Reduction of histamine-induced broncho-constriction by magnesium in asthmatic subjects. Allergy 42, 186-188.
188. Altura, B.M. & Altura, B.T. (1990): Role of magnesium in the pathogenesis of hypertension - relationship to its actions on cardiac and vascular smooth muscle. Hypertension 1-2, 1003-1025.
189. Bertelloni, S. (1992): The parathyroid hormone-1,25-dihydroxyvitamin D endocrine system and magnesium status in insulin-dependent diabetes mellitus: current concepts. Magnes. Res. 5, 45-51.
190. 3 administration on lymphoproliferation and autoimmune disease in MRL/MP-lpr/lpr mice. Int. Arch. Aliergy. Appl. Immun. 77, 396-404.
191. Walters, M.R., Kollenkirchen, U. & Fox, J. (1992): What is vitamin D deficiency? Proc. Soc. Exp. Biol. Med. 199, 385-393.
192. Bac, P., Pages, N., Herrenknecht, C. & Teste, J.-G. (1995): Inhibition of mouse-killing behaviour in magnesium-deficient rats: effect of pharmacological doses of magnesium pidolate, magnesium aspartate, magnesium lactate, magnesium gluconate and magnesium chloride. Magnes. Res. 8, 37-45.
193. McKenna, M.J. (1992): Differences in vitamin D status between countries in young adults and the elderly. Am. J. Med. 93, 69-77.
194. Costello, R.B. & Moser-Veillon, P.S. (1992): A review of magnesium intake in the elderly. A cause for concern? Magnes. Res. 5, 61-67.
195. Durlach, J., Durlach, V., Rayssiguier, Y., Bara, M. & Guiet-Bara, A. (1992): Chapter 114. Magnesium and the cardiovascular system: II. Clinical data. A critical review. In: Molecular biology of atherosclerosis, ed. M.J. Halpern, pp. 513-521. London: John Libbey.
196. Rayssiguier, Y., Durlach, J., Gueux, E., Rock, E. & Mazur, A. (1993): Magnesium and ageing. I. Experimental data: importance of oxidative damage. Magnes. Res. 6, 369-378.
197. Durlach, J., Durlach, V., Bac, P., Rayssiguier, Y., Bara, M. & Guiet-Bara, A. (1993): Magnesium and ageing. II. Clinical data: aetological mechanisms and pathophysiological consequences of magnesium deficit in the elderly. Magnes. Res. 6, 379-394.